[Urinary tract infections and antibiotic resistance].
Urinary tract infections (UTI) usually are monoinfections caused by the endogenous microflora including gram-negatives, such as Escherichia coli, or gram-positives, like enterococci. This allows for an empiric treatment of uncomplicated UTIs and a short duration of therapy to minimize the probability for the development of resistance. Resistance often is based upon mutations altering the drug target (sulfonamides, trimethoprim, fluoroquinolones, fosfomycin) or acquisition of resistance genes (beta-lactams). The latter can be collocated with other resistance genes on mobile genetic elements mediating multiple drug resistance. Such elements are part of the chromosome of the Escherichia coli clonal group A (cgA). The prevalence of resistance to nitrofurantoin and fosfomycin is below 6%, while that of sulfonamide/trimethoprim varies between 15 and 50% all over Europe. Resistance to fluoroquinolones and amoxycillin approximates 15 and over 30%, respectively. A value of >20% for the empiric treatment of uncomplicated UTIs is associated with a significantly increased duration of therapy suggesting alternative antibiotic regimens.
Heisig
P
P
Pharmazeutische Biologie und Mikrobiologie, Department Chemie, Universität Hamburg, Bundesstrasse 45, 20146, Hamburg, Deutschland. heisig@chemie.uni-hamburg.de
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D003430:Cross-Sectional Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D024881:Drug Resistance, Bacterial; D005260:Female; D006306:Health Surveys; D006801:Humans; D007362:Intensive Care Units; D008826:Microbial Sensitivity Tests; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D055815:Young Adult
D000900:Anti-Bacterial Agents
Obstet Gynecol Surv. 1989 May;44(5):399-406
2657522
Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:65-72
14527774
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:11-32
18154525
J Antimicrob Chemother. 1998 Sep;42(3):363-71
9786476
Nat Rev Microbiol. 2006 Aug;4(8):608-20
16845431
Prim Care. 2008 Jun;35(2):345-67, vii
18486719
J Antimicrob Chemother. 2009 Jan;63(1):1-4
18957393
Planta Med. 2001 Feb;67(1):3-12
11270718
Clin Microbiol Rev. 2009 Oct;22(4):664-89
19822894
Urology. 2006 Dec;68(6):1169-74
17169640
Am J Med. 2008 Oct;121(10):876-84
18823859
Int J Antimicrob Agents. 2006 Jun;27(6):468-75
16713191
Mutagenesis. 2009 Nov;24(6):465-9
19762349
Curr Opin Infect Dis. 2006 Feb;19(1):67-71
16374221
J Antimicrob Chemother. 2003 Jan;51(1):69-76
12493789
Lancet. 2001 Apr 28;357(9265):1325-8
11343738
Antimicrob Agents Chemother. 2009 Jun;53(6):2283-8
19364861